Last updated: 11/04/2018 13:43:41
Survey on the pharmacy follow-up of Alli purchasers
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Survey on the pharmacy follow up of Alli purchasers
Trial description: To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Change in Physical activity
Timeframe: baseline to 1 year
Secondary outcomes:
Change in dietary behavior
Timeframe: baseline to 1 year
Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)
Timeframe: baseline to 1 year
Satisfaction with management (i.e., results on weight and treatment comfort)
Timeframe: baseline to 1 year
Interventions:
Drug: Orlistat
Enrollment:
80
Observational study model:
Cohort
Primary completion date:
2010-31-12
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Overweight
Product
Not applicable
Collaborators
Not applicable
Study date(s)
January 2010 to December 2010
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
No
- Inclusion Criteria:
- Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.
Inclusion and exclusion criteria
Inclusion criteria:
- Inclusion Criteria:
- Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.
Trial location(s)
No location data available.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
2010-31-12
Actual study completion date
2010-31-12
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website